Latest Insider Transactions at Re Shape Lifesciences Inc. (RSLS)
This section provides a real-time view of insider transactions for Re Shape Lifesciences Inc. (RSLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ReShape Lifesciences Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ReShape Lifesciences Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 30
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+31.5%
|
$45,000
$3.43 P/Share
|
|
Aug 20
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+45.99%
|
$45,000
$3.22 P/Share
|
|
Jul 22
2021
|
Lori Courtney Mc Dougal Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Arda Phd Minocherhomjee Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
253,429
+50.0%
|
-
|
|
Jul 22
2021
|
Dan W Gladney Director |
BUY
Grant, award, or other acquisition
|
Direct |
483,922
+50.0%
|
-
|
|
Jul 22
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
372,744
+32.69%
|
-
|
|
Jul 22
2021
|
Barton P. Bandy President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,186,006
+33.0%
|
-
|
|
Jun 28
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
0
|
-
|
|
Jun 28
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
7,130,806
+23.72%
|
-
|
|
Jun 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 18
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
685,583
-86.62%
|
$3,427,915
$5.48 P/Share
|
|
Jun 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 17
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,106,210
-31.66%
|
$6,637,260
$6.67 P/Share
|
|
Jun 16
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 16
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
511,676
-7.44%
|
$3,581,732
$7.65 P/Share
|